April 27, 2026 · Gut · DOI: 10.1136/gutjnl-2025-337965

The UK experience with hepatitis B immunoglobulin use following liver transplantation: wide variation in practice despite evidence supporting cost-effective HBIG-free prophylaxis

Listen to this summary

This study investigates the current practices and outcomes of hepatitis B immunoglobulin (HBIG) use for prophylaxis against hepatitis B virus recurrence following liver transplantation in the UK. The authors found significant variability in HBIG protocols among transplant centers, with most patients receiving HBIG regardless of their recurrence risk, yet the findings suggest that HBIG maintenance-free strategies could be both feasible and cost-effective, as they do not significantly impact patient outcomes. The study calls for further prospective research to validate these results and promote broader adoption of HBIG-free approaches.

Almuthana Mohamed, Maria Guerra Veloz, Lindsay Greenland, Silke Francois, Gemma Botterill, Rachel Smith, Muhammad Salman, Lucy Turner, Alison Rowley, Stuart McPherson, Andrew Bathgate, Douglas Thorburn, William Gelson, Mark Aldersley, Patrick T F Kennedy, Kosh Agarwal, Ahmed M Elsharkawy

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play